Skip to main content
. Author manuscript; available in PMC: 2013 Aug 16.
Published in final edited form as: Cancer Res. 2013 Mar 27;73(7):2159–2169. doi: 10.1158/0008-5472.CAN-12-1962

Figure 6.

Figure 6

Loss of β2SP increases oncogenic potential in esophageal adenocarcinoma cells. A, flow cytometry analysis using Oct3/4 antibody in esophageal adenocarcinoma cells with control or shβ2SP was conducted. B, bar graph showed the difference of OCT3/4 positive cells in control and shβ2SP cells. C, tumor sphere assays were done in SKGT-4 cells with modified β2SP and or SOX9 level as described in Materials and Methods. Representative fields are shown in C (left) and the bar graph in C (right). D, Matrigel-invasion assays were done in SKGT-4 cells (1 × 105) with modified β2SP or SOX9 as indicated in Materials and Methods. Representative fields are shown in D (left) and the bar graph in D (right). Experiments conducted in triplicate; bars, standard errors, *, P < 0.05 or lower.